Animal Drug Compounding Market - Growth, Future Prospects and Competitive Analysis, 2024

Description

List of Tables

The animal drug compounding market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032, fueled by innovative compounding practices, a focus on companion animal healthcare, and the rising prevalence of animal diseases. While regulatory challenges pose considerations, the market's segmentation reveals diverse trends, with certain segments like Anti-infectives, companion animal drugs, capsules, and oral administration leading in both revenue and CAGR. Geographically, North America stands out as a frontrunner, indicative of the region's proactive approach toward personalized animal healthcare. The competitive landscape showcases key players navigating the market through strategic initiatives. This factual overview provides a comprehensive understanding of the market dynamics, setting the stage for informed decision-making in the evolving landscape of animal drug compounding.

Key Market Drivers

Innovative Compounding Practices

The market experiences a surge driven by innovative compounding practices, enhancing the availability and efficacy of customized animal drugs. Veterinarians increasingly leverage compounding to address specific therapeutic requirements, promoting better treatment outcomes. Evidence suggests a growing adoption of compounding techniques, exemplified by the expansion of compounding pharmacies and tailored drug formulations.

Growing Focus on Companion Animal Healthcare

The increasing emphasis on companion animal health serves as a significant driver. With rising pet ownership and a cultural shift toward viewing pets as family members, there is a heightened demand for specialized compounded medications tailored to individual animal needs. This trend is substantiated by an uptick in spending on companion animal healthcare services and products.

Rising Prevalence of Animal Diseases

The surge in animal diseases, particularly chronic conditions, propels the demand for compounded drugs. Evidence indicates a notable increase in the incidence of conditions requiring specialized treatments, such as chronic pain management and dermatological issues. Compounded drugs address these specific health challenges, contributing to the market's upward trajectory.

Restraint: Regulatory Challenges and Compliance Issues

Despite the market's growth, regulatory challenges and compliance issues emerge as significant restraints. Evidence points to instances where compounding practices face scrutiny due to concerns about quality control, standardization, and adherence to regulatory guidelines. These challenges pose a potential impediment to the seamless expansion of the animal drug compounding market.

Market Segmentation Analysis

Market by Product

In 2023, the market witnessed diverse product segments, including Anti-infectives, Anti-inflammatories, CNS Agents, GI Drugs, and others. Anti-infectives led in both the highest revenue and CAGR, showcasing their critical role in addressing a spectrum of infections. The forecast expects sustained leadership, emphasizing the continued demand for effective animal infection management.

Market by Animal Type

Companion animals and livestock represented the primary animal types in the market. In 2023, companion animal drugs led in both revenue and CAGR. The bond between pet owners and their animals drives the demand for specialized medications, indicating a sustained focus on companion animal healthcare in the forecast period.

Market by Dosage Form

Dosage forms, including capsules, solutions, powders, suspensions, and others, marked the market segmentation. Capsules emerged as the leader in both revenue and CAGR in 2023, reflecting their ease of administration and precise dosing. The forecast anticipates capsules to maintain their dominance, aligning with consumer preferences for convenient and accurately dosed medications.

Market by Route of Administration

The route of administration, encompassing oral, injectable, topical, rectal, and ocular routes, witnessed diverse preferences. In 2023, oral administration led in both the highest revenue and CAGR. The ease of oral drug administration and patient compliance contribute to the sustained prominence of this route in the forecast period.

North America Remains the Global Leader

Geographically, the market exhibits trends shaped by regional preferences and healthcare landscapes. North America, with its established veterinary infrastructure and a high focus on companion animal healthcare, led to both the highest revenue in 2023 and CAGR during the forecast period of 2024 to 2032. The region's proactive adoption of innovative compounding practices and a growing awareness of personalized animal healthcare contribute to this leadership position.

Strategic Collaborations to Enhance Market Share

The animal drug compounding market is characterized by the presence of key players adopting strategic measures to solidify their positions. Leading companies such as Wedgewood Pharmacy, Diamondback Drugs, Roadrunner Pharmacy, Vimian, Pharmaca., Akina Animal Health, Triangle Compounding., Davis Islands Pharmacy and Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South., Wellness Pharmacy of Cary., and Miller's Pharmacy are notable players in the industry, contributing to the market's dynamic landscape. Top companies are strategically engaging in partnerships and collaborations with veterinary clinics and healthcare providers. These collaborations aim to enhance the accessibility of compounded drugs and streamline the integration of innovative compounding practices into veterinary care. The companies are also focusing on developing novel formulations and dosage forms to address evolving veterinary healthcare needs. By staying at the forefront of pharmaceutical innovation, companies are aiming to maintain a competitive edge in the market. In summary, competitive trends in the animal drug compounding market involve strategic partnerships, research and development initiatives, regulatory compliance, emphasis on specialized medications, and the expansion of service offerings.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Animal Drug Compounding market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Animal Drug Compounding market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Anti-infectives

Metranidazole

Ketaconazole

Others

Anti-inflammatory

Prednisolone

Tramadol

Others

CNS Agents

Potassium Bromide

Gabapentin

Other CNS Agents

GI Drugs

Apomorphine

Ursodiol

Cisapride

Other GI Drugs

Others

Methimazole

Others

Animal Type

Companion Animal

Dogs

Cats

Others

Livestock

Dosage Form

Capsules

Solutions

Powders

Suspension

Others

Route of Administration

Oral

Injectable

Topical

Rectal

Ocular

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Animal Drug Compounding market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Animal Drug Compounding market?

Which is the largest regional market for Animal Drug Compounding market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Animal Drug Compounding market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Animal Drug Compounding market worldwide?

Product Code: 140204-04-24

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Animal Drug Compounding Market
2.2. Global Animal Drug Compounding Market, By Product, 2023 (US$ Million)
2.3. Global Animal Drug Compounding Market, By Animal Type, 2023 (US$ Million)
2.4. Global Animal Drug Compounding Market, By Dosage Form, 2023 (US$ Million)
2.5. Global Animal Drug Compounding Market, By Route of Administration, 2023 (US$ Million)
2.6. Global Animal Drug Compounding Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023

3. Animal Drug Compounding Market: Competitive Analysis

3.1. Market Positioning of Key Animal Drug Compounding Market Vendors
3.2. Strategies Adopted by Animal Drug Compounding Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Animal Drug Compounding Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Animal Drug Compounding Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape

5. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
- 5.3.1. Anti-infectives
  - 5.3.1.1. Metranidazole
  - 5.3.1.2. Ketaconazole
  - 5.3.1.3. Others
- 5.3.2. Anti-inflammatory
  - 5.3.2.1. Prednisolone
  - 5.3.2.2. Tramadol
  - 5.3.2.3. Others
- 5.3.3. CNS Agents
  - 5.3.3.1. Potassium Bromide
  - 5.3.3.2. Gabapentin
  - 5.3.3.3. Other CNS Agents
- 5.3.4. GI Drugs
  - 5.3.4.1. Apomorphine
  - 5.3.4.2. Ursodiol
  - 5.3.4.3. Cisapride
  - 5.3.4.4. Other GI Drugs
- 5.3.5. Others
  - 5.3.5.1. Methimazole
  - 5.3.5.2. Others

6. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
- 6.3.1. Companion Animal
  - 6.3.1.1. Dogs
  - 6.3.1.2. Cats
  - 6.3.1.3. Others
- 6.3.2. Livestock

7. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
- 7.3.1. Capsules
- 7.3.2. Solutions
- 7.3.3. Powders
- 7.3.4. Suspension
- 7.3.5. Others

8. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)

8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
- 8.3.1. Oral
- 8.3.2. Injectable
- 8.3.3. Topical
- 8.3.4. Rectal
- 8.3.5. Ocular

9. North America Animal Drug Compounding Market, 2022-2032, USD (Million)

9.1. Market Overview
9.2. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
9.3. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
9.4. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
9.5. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
9.6.Animal Drug Compounding Market: By Region, 2022-2032, USD (Million)
- 9.6.1.North America
  - 9.6.1.1. U.S.
    - 9.6.1.1.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 9.6.1.1.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 9.6.1.1.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 9.6.1.1.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 9.6.1.2. Canada
    - 9.6.1.2.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 9.6.1.2.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 9.6.1.2.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 9.6.1.2.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 9.6.1.3. Rest of North America
    - 9.6.1.3.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 9.6.1.3.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 9.6.1.3.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 9.6.1.3.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)

10. UK and European Union Animal Drug Compounding Market, 2022-2032, USD (Million)

10.1. Market Overview
10.2. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
10.3. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
10.4. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
10.5. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
10.6.Animal Drug Compounding Market: By Region, 2022-2032, USD (Million)
- 10.6.1.UK and European Union
  - 10.6.1.1. UK
    - 10.6.1.1.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.1.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 10.6.1.1.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 10.6.1.1.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 10.6.1.2. Germany
    - 10.6.1.2.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.2.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 10.6.1.2.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 10.6.1.2.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 10.6.1.3. Spain
    - 10.6.1.3.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.3.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 10.6.1.3.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 10.6.1.3.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 10.6.1.4. Italy
    - 10.6.1.4.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.4.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 10.6.1.4.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 10.6.1.4.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 10.6.1.5. France
    - 10.6.1.5.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.5.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 10.6.1.5.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 10.6.1.5.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 10.6.1.6. Rest of Europe
    - 10.6.1.6.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 10.6.1.6.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 10.6.1.6.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 10.6.1.6.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)

11. Asia Pacific Animal Drug Compounding Market, 2022-2032, USD (Million)

11.1. Market Overview
11.2. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
11.3. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
11.4. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
11.5. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
11.6.Animal Drug Compounding Market: By Region, 2022-2032, USD (Million)
- 11.6.1.Asia Pacific
  - 11.6.1.1. China
    - 11.6.1.1.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.1.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 11.6.1.1.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 11.6.1.1.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 11.6.1.2. Japan
    - 11.6.1.2.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.2.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 11.6.1.2.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 11.6.1.2.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 11.6.1.3. India
    - 11.6.1.3.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.3.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 11.6.1.3.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 11.6.1.3.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 11.6.1.4. Australia
    - 11.6.1.4.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.4.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 11.6.1.4.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 11.6.1.4.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 11.6.1.5. South Korea
    - 11.6.1.5.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.5.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 11.6.1.5.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 11.6.1.5.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 11.6.1.6. Rest of Asia Pacific
    - 11.6.1.6.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 11.6.1.6.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 11.6.1.6.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 11.6.1.6.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)

12. Latin America Animal Drug Compounding Market, 2022-2032, USD (Million)

12.1. Market Overview
12.2. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
12.3. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
12.4. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
12.5. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
12.6.Animal Drug Compounding Market: By Region, 2022-2032, USD (Million)
- 12.6.1.Latin America
  - 12.6.1.1. Brazil
    - 12.6.1.1.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 12.6.1.1.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 12.6.1.1.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 12.6.1.1.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 12.6.1.2. Mexico
    - 12.6.1.2.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 12.6.1.2.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 12.6.1.2.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 12.6.1.2.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 12.6.1.3. Rest of Latin America
    - 12.6.1.3.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 12.6.1.3.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 12.6.1.3.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 12.6.1.3.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)

13. Middle East and Africa Animal Drug Compounding Market, 2022-2032, USD (Million)

13.1. Market Overview
13.2. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
13.3. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
13.4. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
13.5. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
13.6.Animal Drug Compounding Market: By Region, 2022-2032, USD (Million)
- 13.6.1.Middle East and Africa
  - 13.6.1.1. GCC
    - 13.6.1.1.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 13.6.1.1.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 13.6.1.1.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 13.6.1.1.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 13.6.1.2. Africa
    - 13.6.1.2.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 13.6.1.2.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 13.6.1.2.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 13.6.1.2.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)
  - 13.6.1.3. Rest of Middle East and Africa
    - 13.6.1.3.1. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)
    - 13.6.1.3.2. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)
    - 13.6.1.3.3. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)
    - 13.6.1.3.4. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)

14. Company Profile

14.1. Wedgewood Pharmacy
- 14.1.1. Company Overview
- 14.1.2. Financial Performance
- 14.1.3. Product Portfolio
- 14.1.4. Strategic Initiatives
14.2. Diamondback Drugs
- 14.2.1. Company Overview
- 14.2.2. Financial Performance
- 14.2.3. Product Portfolio
- 14.2.4. Strategic Initiatives
14.3. Roadrunner Pharmacy
- 14.3.1. Company Overview
- 14.3.2. Financial Performance
- 14.3.3. Product Portfolio
- 14.3.4. Strategic Initiatives
14.4. Vimian
- 14.4.1. Company Overview
- 14.4.2. Financial Performance
- 14.4.3. Product Portfolio
- 14.4.4. Strategic Initiatives
14.5. Pharmaca.
- 14.5.1. Company Overview
- 14.5.2. Financial Performance
- 14.5.3. Product Portfolio
- 14.5.4. Strategic Initiatives
14.6. Akina Animal Health
- 14.6.1. Company Overview
- 14.6.2. Financial Performance
- 14.6.3. Product Portfolio
- 14.6.4. Strategic Initiatives
14.7. Triangle Compounding.
- 14.7.1. Company Overview
- 14.7.2. Financial Performance
- 14.7.3. Product Portfolio
- 14.7.4. Strategic Initiatives
14.8. Davis Islands Pharmacy and Compounding Lab
- 14.8.1. Company Overview
- 14.8.2. Financial Performance
- 14.8.3. Product Portfolio
- 14.8.4. Strategic Initiatives
14.9. Custom Med Compounding Pharmacy
- 14.9.1. Company Overview
- 14.9.2. Financial Performance
- 14.9.3. Product Portfolio
- 14.9.4. Strategic Initiatives
14.10. Central Compounding Center South.
- 14.10.1. Company Overview
- 14.10.2. Financial Performance
- 14.10.3. Product Portfolio
- 14.10.4. Strategic Initiatives
14.11. Wellness Pharmacy of Cary.
- 14.11.1. Company Overview
- 14.11.2. Financial Performance
- 14.11.3. Product Portfolio
- 14.11.4. Strategic Initiatives
14.12. Miller's Pharmacy
- 14.12.1. Company Overview
- 14.12.2. Financial Performance
- 14.12.3. Product Portfolio
- 14.12.4. Strategic Initiatives
14.13. Other Notable Players
- 14.13.1. Company Overview
- 14.13.2. Financial Performance
- 14.13.3. Product Portfolio
- 14.13.4. Strategic Initiatives

Product Code: 140204-04-24

List of Tables

TABLE 1 Global Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 2 Global Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 3 Global Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 4 Global Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 5 Global Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 6 Global Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 7 Global Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 8 Global Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 9 Global Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 10 Global Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 11 North America Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 12 North America Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 13 North America Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 14 North America Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 15 North America Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 16 North America Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 17 North America Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 18 North America Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 19 North America Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 20 North America Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 21 U.S. Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 22 U.S. Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 23 U.S. Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 24 U.S. Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 25 U.S. Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 26 U.S. Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 27 U.S. Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 28 U.S. Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 29 U.S. Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 30 U.S. Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 31 Canada Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 32 Canada Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 33 Canada Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 34 Canada Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 35 Canada Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 36 Canada Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 37 Canada Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 38 Canada Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 39 Canada Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 40 Canada Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 41 Rest of North America Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 42 Rest of North America Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 43 Rest of North America Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 44 Rest of North America Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 45 Rest of North America Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 46 Rest of North America Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 47 Rest of North America Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 48 Rest of North America Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 49 Rest of North America Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 50 Rest of North America Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 51 UK and European Union Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 52 UK and European Union Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 53 UK and European Union Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 54 UK and European Union Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 55 UK and European Union Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 56 UK and European Union Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 57 UK and European Union Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 58 UK and European Union Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 59 UK and European Union Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 60 UK and European Union Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 61 UK Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 62 UK Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 63 UK Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 64 UK Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 65 UK Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 66 UK Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 67 UK Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 68 UK Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 69 UK Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 70 UK Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 71 Germany Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 72 Germany Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 73 Germany Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 74 Germany Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 75 Germany Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 76 Germany Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 77 Germany Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 78 Germany Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 79 Germany Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 80 Germany Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 81 Spain Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 82 Spain Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 83 Spain Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 84 Spain Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 85 Spain Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 86 Spain Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 87 Spain Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 88 Spain Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 89 Spain Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 90 Spain Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 91 Italy Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 92 Italy Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 93 Italy Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 94 Italy Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 95 Italy Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 96 Italy Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 97 Italy Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 98 Italy Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 99 Italy Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 100 Italy Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 101 France Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 102 France Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 103 France Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 104 France Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 105 France Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 106 France Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 107 France Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 108 France Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 109 France Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 110 France Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 111 Rest of Europe Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 112 Rest of Europe Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 113 Rest of Europe Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 114 Rest of Europe Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 115 Rest of Europe Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 116 Rest of Europe Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 117 Rest of Europe Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 118 Rest of Europe Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 119 Rest of Europe Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 120 Rest of Europe Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 121 Asia Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 122 Asia Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 123 Asia Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 124 Asia Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 125 Asia Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 126 Asia Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 127 Asia Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 128 Asia Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 129 Asia Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 130 Asia Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 131 China Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 132 China Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 133 China Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 134 China Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 135 China Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 136 China Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 137 China Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 138 China Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 139 China Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 140 China Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 141 Japan Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 142 Japan Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 143 Japan Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 144 Japan Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 145 Japan Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 146 Japan Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 147 Japan Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 148 Japan Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 149 Japan Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 150 Japan Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 151 India Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 152 India Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 153 India Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 154 India Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 155 India Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 156 India Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 157 India Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 158 India Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 159 India Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 160 India Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 161 Australia Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 162 Australia Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 163 Australia Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 164 Australia Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 165 Australia Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 166 Australia Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 167 Australia Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 168 Australia Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 169 Australia Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 170 Australia Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 171 South Korea Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 172 South Korea Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 173 South Korea Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 174 South Korea Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 175 South Korea Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 176 South Korea Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 177 South Korea Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 178 South Korea Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 179 South Korea Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 180 South Korea Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 181 Latin America Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 182 Latin America Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 183 Latin America Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 184 Latin America Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 185 Latin America Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 186 Latin America Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 187 Latin America Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 188 Latin America Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 189 Latin America Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 190 Latin America Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 191 Brazil Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 192 Brazil Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 193 Brazil Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 194 Brazil Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 195 Brazil Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 196 Brazil Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 197 Brazil Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 198 Brazil Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 199 Brazil Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 200 Brazil Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 201 Mexico Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 202 Mexico Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 203 Mexico Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 204 Mexico Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 205 Mexico Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 206 Mexico Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 207 Mexico Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 208 Mexico Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 209 Mexico Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 210 Mexico Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 211 Rest of Latin America Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 212 Rest of Latin America Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 213 Rest of Latin America Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 214 Rest of Latin America Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 215 Rest of Latin America Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 216 Rest of Latin America Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 217 Rest of Latin America Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 218 Rest of Latin America Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 219 Rest of Latin America Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 220 Rest of Latin America Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 221 Middle East and Africa Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 222 Middle East and Africa Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 223 Middle East and Africa Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 224 Middle East and Africa Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 225 Middle East and Africa Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 226 Middle East and Africa Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 227 Middle East and Africa Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 228 Middle East and Africa Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 229 Middle East and Africa Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 230 Middle East and Africa Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 231 GCC Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 232 GCC Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 233 GCC Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 234 GCC Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 235 GCC Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 236 GCC Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 237 GCC Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 238 GCC Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 239 GCC Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 240 GCC Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 241 Africa Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 242 Africa Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 243 Africa Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 244 Africa Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 245 Africa Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 246 Africa Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 247 Africa Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 248 Africa Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 249 Africa Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 250 Africa Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)
TABLE 251 Rest of Middle East and Africa Animal Drug Compounding Market By Product, 2022-2032, USD (Million)
TABLE 252 Rest of Middle East and Africa Animal Drug Compounding Market By Anti-infectives, 2022-2032, USD (Million)

TABLE 253 Rest of Middle East and Africa Animal Drug Compounding Market By Anti-inflammatory, 2022-2032, USD (Million)

TABLE 254 Rest of Middle East and Africa Animal Drug Compounding Market By CNS Agents, 2022-2032, USD (Million)

TABLE 255 Rest of Middle East and Africa Animal Drug Compounding Market By GI Drugs, 2022-2032, USD (Million)

TABLE 256 Rest of Middle East and Africa Animal Drug Compounding Market By Others, 2022-2032, USD (Million)

TABLE 257 Rest of Middle East and Africa Animal Drug Compounding Market By Animal Type, 2022-2032, USD (Million)

TABLE 258 Rest of Middle East and Africa Animal Drug Compounding Market By Companion Animal, 2022-2032, USD (Million)

TABLE 259 Rest of Middle East and Africa Animal Drug Compounding Market By Dosage Form, 2022-2032, USD (Million)

TABLE 260 Rest of Middle East and Africa Animal Drug Compounding Market By Route of Administration, 2022-2032, USD (Million)

List of Figures

FIG. 1 Global Animal Drug Compounding Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Animal Drug Compounding Market: Quality Assurance
FIG. 5 Global Animal Drug Compounding Market, By Product, 2023
FIG. 6 Global Animal Drug Compounding Market, By Animal Type, 2023
FIG. 7 Global Animal Drug Compounding Market, By Dosage Form, 2023
FIG. 8 Global Animal Drug Compounding Market, By Route of Administration, 2023
FIG. 9 Global Animal Drug Compounding Market, By Geography, 2023
FIG. 10 Market Geographical Opportunity Matrix - Global Animal Drug Compounding Market, 2023

FIG. 11Market Positioning of Key Animal Drug Compounding Market Players, 2023

FIG. 12Global Animal Drug Compounding Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

FIG. 13 Global Animal Drug Compounding Market, By Product, 2023 Vs 2032, %
FIG. 14 Global Animal Drug Compounding Market, By Animal Type, 2023 Vs 2032, %
FIG. 15 Global Animal Drug Compounding Market, By Dosage Form, 2023 Vs 2032, %
FIG. 16 Global Animal Drug Compounding Market, By Route of Administration, 2023 Vs 2032, %
FIG. 17 U.S. Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 18 Canada Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 19 Rest of North America Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 20 UK Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 21 Germany Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 22 Spain Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 23 Italy Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 24 France Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 25 Rest of Europe Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 26 China Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 27 Japan Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 28 India Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 29 Australia Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 30 South Korea Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 31 Rest of Asia Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 32 Brazil Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 33 Mexico Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 34 Rest of Latin America Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 35 GCC Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 36 Africa Animal Drug Compounding Market (US$ Million), 2022 - 2032
FIG. 37 Rest of Middle East and Africa Animal Drug Compounding Market (US$ Million), 2022 - 2032

Animal Drug Compounding Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032

Description

Table of Contents

List of Tables

Table of Contents

1. Preface

2. Executive Summary

3. Animal Drug Compounding Market: Competitive Analysis

4. Animal Drug Compounding Market: Macro Analysis & Market Dynamics

5. Animal Drug Compounding Market: By Product, 2022-2032, USD (Million)

6. Animal Drug Compounding Market: By Animal Type, 2022-2032, USD (Million)

7. Animal Drug Compounding Market: By Dosage Form, 2022-2032, USD (Million)

8. Animal Drug Compounding Market: By Route of Administration, 2022-2032, USD (Million)

9. North America Animal Drug Compounding Market, 2022-2032, USD (Million)

10. UK and European Union Animal Drug Compounding Market, 2022-2032, USD (Million)

11. Asia Pacific Animal Drug Compounding Market, 2022-2032, USD (Million)

12. Latin America Animal Drug Compounding Market, 2022-2032, USD (Million)

13. Middle East and Africa Animal Drug Compounding Market, 2022-2032, USD (Million)

14. Company Profile

List of Tables

List of Figures